Nanoparticles of sodium cromoglycate for the treatment of asthma
- At: 2014 FIP Congress in Bangkok (Thailand)
- Type: Poster
- By: GOLI, Divakar (Acharya & BM Reddy College of Pharmacy, Pharmaceutical Technology, Bangalore, India)
- Co-author(s): Shah, Hk (Acharya & BM Reddy College of Pharmacy, Bangalore, India)
Divakar, Kalyani (Acharya & BM Reddy College of Pharmacy, Bangalore, India)
Sodium cromoglycate is mast cell stabilizer and is used in the management of chronic asthma. It has 8 to 10% bioavailability on inhalation and has short half life of 1.3h. The purpose of the present research work was to increase bioavailability of Sodium cromoglycate and reduce dosing frequency by formulating mucoadhesive chitosan nanoparticles.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.